Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|November 1, 1992
Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arraysD E Symer, R Z Dintzis, D J Diamond, et al.
The Journal of Surgical Research|May 1, 1997
The use of transgenic mice to generate high affinity p53 specific cytolytic T cellsZ Yu, X Liu, T M McCarty, et al.
Annals of Surgical Oncology|April 3, 1998
An HLA-restricted, p53 specific immune response from HLA transgenic p53 knockout miceT M McCarty, Z Yu, X Liu, et al.
Blood|September 18, 1997
Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infectionD J Diamond, J York, J Y Sun, et al.
Human Immunology|September 12, 2000
Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) responseL BenMohamed, R Krishnan, J Longmate, et al.
Surgery|September 16, 1999
An orthotopic in vivo model of human pancreatic cancerR E Schwarz, T M McCarty, E A Peralta, et al.
Immunogenetics|February 28, 2001
Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopesJ Longmate, J York, C La Rosa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 15, 2010
Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus diseaseA Krishnan, W Zhou, S F Lacey, et al.
Bone Marrow Transplantation|September 23, 2014
Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantationA Israyelyan, L Goldstein, W Tsai, et al.
Cancer Research|July 4, 1998
Targeting p53 for adoptive T-cell immunotherapyT M McCarty, X Liu, J Y Sun, et al.
Pageof 4